Ganitumab (AMG 479) Inhibits IGF-II-Dependent Ovarian Cancer Growth and Potentiates Platinum-Based ChemotherapyBELTRAN, Pedro J; CALZONE, Frank J; GUORONG YANG et al.Clinical cancer research (Print). 2014, Vol 20, Num 11, pp 2947-2958, issn 1078-0432, 12 p.Article

Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian CancerKONECNY, Gottfried E; WINTERHOFF, Boris; KALLI, Kimberly R et al.Clinical cancer research (Print). 2011, Vol 17, Num 6, pp 1591-1602, issn 1078-0432, 12 p.Article